Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
In recent years it has been shown that the causes of chronic myeloproliferative neoplasms (MPNs) are more complex than a simple signaling aberration and many other mutated genes affecting different cell processes have been described. For instance, mutations in genes encoding epigenetic regulators are more frequent than expected. One of the latest genes described as mutated is (). tools have revealed that there are several human paralogous to (), and , for example, which are also involved in the development of other hematological malignancies. Therefore, the present study analyzed the mutational status of and in negative MPNs with or without () p.V617F mutation. The present study revealed that the NSD genes are not frequently mutated in MPNs. However, a novel mutation was identified in a patient with p.V617F positive primary myelofibrosis. These results provide further insight into the genetic complexity of MPNs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482393 | PMC |
http://dx.doi.org/10.3892/mco.2019.1840 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!